Description
SARS-CoV Spike Protein. Cat# abx060655. Supplier: abbexa.
SARS-CoV Spike Protein (Recombinant) is a infectious disease antigen or toxin. This is a protein corresponding to the C-terminal region of SARS-CoV Spike Protein.
| Target | SARS-CoV Spike |
| Origin | Virus |
| Expression | Recombinant |
| Tested Applications | ELISA, WB |
| Host | E. coli |
| Recommended dilutions | Optimal dilutions/concentrations should be determined by the end user. |
| Conjugation | Unconjugated |
| Form | Liquid |
| Purity | > 95% (10% PAGE, Coomassie staining) |
| Purification | GS-4B Sepharose-Affinity Purification |
| Storage | Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles. |
| UniProt Primary AC | P59594 (UniProt, ExPASy) |
| UniProt Secondary AC | Q6QU82, Q7T696, Q7TA19, Q7TFA2, Q7TFB1, Q80BV6 |
| UniProt Entry Name | SPIKE_CVHSA |
| Gene Symbol | S |
| GeneID | 1489668 |
| KEGG | vg:1489668 |
| Molecular Weight | 37 kDa. May appear as multiple bands on SDS-PAGE (intact protein at 37 kDa, GST fusion protein at 26 kDa, and the Spike fragment at 11 kDa). |
| Sequence Fragment | Contains a mosaic of the immunodominant regions of the C-terminal of the Spike protein. Not full-length spike protein. The exact sequence is proprietary. |
| Tag | GST tag |
| Buffer | 25 mM Tris-HCl, 0.4% Sarcosyl, 0.25% Triton-X100, 50% Glycerol. Does not contain preservatives. |
| Specificity | Immunoreactive with SARS positive sera. |
| Concentration | 1 mg/ml |
| Directions for use | Centrifuge before opening to ensure complete recovery of vial contents. |
| Availability | Shipped within 5-10 working days. |
| Note | This product is for research use only.
Not for human consumption, cosmetic, therapeutic or diagnostic use. |